Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Net Loss Per Share

Schedule of basic and diluted net loss per share

	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands, except share and per share data)	2022		2021		2022		2021
Numerator:
Net loss attributable to CASI Pharmaceuticals, Inc.	$	(5,201)		(10,224)	$	(21,477)	$	(31,053)
Denominator:
Weighted average number of common stock		13,606,130		13,979,636		13,668,553		13,486,024
Denominator for basic and diluted net loss per share calculation		13,606,130		13,979,636		13,668,553		13,486,024
Net loss per share
— Basic and diluted	$	(0.38)	$	(0.73)	$	(1.57)	$	(2.30)